Quantcast

Latest Biomarkers Stories

2014-05-02 12:27:01

MUMBAI, May 2, 2014 /PRNewswire/ -- Bharat Book Bureau presents Global & USA Cancer Biomarker Market to 2018. It is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized medicine, companion diagnostics and the associated market environment. https://www.bharatbook.com/medical-devices-market-research-reports-489693 Cancer biomarkers are...

2014-04-24 08:34:08

Beckman Coulter's Prostate Health Index (phi) Available Nationwide for Better Prostate Cancer Detection BREA, Calif., April 24, 2014 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non-invasive blood test that is three times more specific in detecting prostate cancer(1) than PSA (prostate-specific antigen). The new test's accuracy decreases the need for many men...

2014-04-23 23:04:09

New research report “Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)” worked out by Kelly Scientific Publications is now available at MarketPublishers.com. London, UK (PRWEB) April 23, 2014 To date, more than 32 million people worldwide are living with cancer. The most frequently occurred types of cancer include breast,...

2014-04-21 08:25:12

- Patented biomarker test designed to predict, monitor and improve patient outcomes PETACH TIKVA, Israel, April 21, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today it has signed an agreement with Smart Assays to develop a commercial biomarker blood test kit for the A3 adenosine receptor (A3AR). Can-Fite's A3AR predictive...

2014-04-18 13:44:32

The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. An analysis of prostate tissue biopsies collected from some participants of the placebo arm of the Prostate Cancer Prevention...

2014-04-16 20:22:43

DUBLIN, April 16, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/btrshd/biomarkers_market) has announced the addition of the "Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts to 2018" [http://www.researchandmarkets.com/research/btrshd/biomarkers_market ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...

2014-04-09 16:25:20

DUBLIN, April 9, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/k3xnm6/molecular) has announced the addition of the "Molecular Diagnostics in Cancer Testing" [http://www.researchandmarkets.com/research/k3xnm6/molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and...

2014-04-08 12:30:37

-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International Ltd will launch two overseas trials of its MiStat(TM) prostate cancer screening test, following an agreement with the prestigious CUSP Group, LLC a Uro-Oncology Trials Management Organisation in the United States. An initial pilot study to be launched in April will examine 300 patient samples and is...

2014-04-08 08:30:12

DUBLIN, April 8, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/tf3qn7/cancer_molecular) has announced the addition of the "Cancer Molecular Biomarkers 2014: A Global Market Study" [http://www.researchandmarkets.com/research/tf3qn7/cancer_molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Technological advances in molecular biology over the last decade are accelerating...

2014-04-08 08:30:06

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tnkqbn/cancer_molecular) has announced the addition of the "Cancer Molecular Diagnostics: Market Developments, Growth Areas and Opportunities 2014" [http://www.researchandmarkets.com/research/tnkqbn/cancer_molecular ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Cancer diagnostics is one of the most dynamic medical...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related